Nouf A. AlAmari

Nouf A. AlAmari

Auto-generated profile, based on publicly available information

Nouf A. AlAmari

Otolaryngology-Head & Neck Surgery Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
AAAsma Alahmadi
Asma Alahmadi
YAYassin Abdelsamad
Yassin Abdelsamad
NANoura Alothman
Noura Alothman
AAAfrah Muteb Alshalan
Afrah Muteb Alshalan
FAFida Almuhawas
Fida Almuhawas
AHAbdulrahman Hagr
Abdulrahman Hagr
Objectives: The present literature review discusses the chronological evolution of Cochlear Implant (CI) activation and its definition among the relevant studies in the literature. In addition, the benefits of standardizing the early activation process in implantation centers worldwide are discussed. Methods: A comprehensive literature search was conducted in the major databases such as PubMed, Scopus, and Embase to retrieve all the relevant articles that reported early activation approaches following CI. Results: The evolution of the timing of early activation after CI has been remarkable in the past few years. Some studies reported the feasibility of early activation 1 day after the CI surgery in their users. Conclusions: Within the last decade, some studies have been published to report the feasibility and outcomes of its early activation. However, the process of early activation was not adequately defined, and no apparent guidelines could be found in the literature.

25 November 2022 in Allergy & Rhinology
Verified
Journal Article
Open access
RARayan Alfallaj
Rayan Alfallaj
GAGhada AlSkait
Ghada AlSkait
NANouf Alamari
Nouf Alamari
LALama Alfawzan
Lama Alfawzan
MAMohammed Abualgasem
Mohammed Abualgasem
SASaad Alsaleh
Saad Alsaleh
Background: Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2, a novel virus that emerged in China in December 2019. In many cases of COVID-19, olfactory dysfunction (OD) is the only symptom. Objectives: This study aimed to examine the incidence of OD in patients with COVID-19 and identify an association between OD and COVID-19-related morbidity and admission. Design: This was a cross-sectional study. Methods: Real-time reverse transcription polymerase chain reaction-confirmed cases of COVID-19 from the Security Forces Hospital electronic registry from June 2020 to September 2020 were included in our study. Data on medical background, severity of the disease, and other related factors were collected through phone calls and electronic healthcare systems and analyzed to investigate OD in the participants. Results: Of the participants, 68% had OD, with a mean recovery time of 18 days and a mean follow-up time of 129 days (76-211 days). OD was negatively correlated with admission and morbidity. Conclusion: OD is a common presentation of COVID-19 and is more prevalent in mild cases of infection.